Background: It is not yet established what specific measures of obesity might be most strongly associated with risk of coronary artery disease. We compared the waist-height ratio to waist-hip ratio, waist circumference, and body mass index as predictors of subsequent coronary heart disease (CHD) in a group of predominantly postmenopausal women. Methods: The data come from the prospective Nurses' Health Study cohort. We included 45,563 women in 1986 who were aged 40 -65 years and were free of heart disease, stroke, and cancer. Waist circumference, hip circumference, height, weight, age, and other covariates were collected by questionnaire. Our primary end point was incident coronary heart disease reported up to June 2002. Areas under the receiver operating characteristic curves (AUCs) were estimated nonparametrically for each of the anthropometric measures. We estimated differences between the AUCs for weightheight ratio and the other measures, with corresponding 95% confidence intervals. We used Cox proportional hazard models to estimate the relationships with risk of CHD. Results: Waist-height ratio, waist-hip ratio, and waist circumference were similar in predicting subsequent risk of CHD. All 3 waistderived measures were superior to body-mass index (BMI) in predicting CHD. The unadjusted AUCs were 0.62 (95% confidence interval ϭ 0.60 -0.64) for waist-height ratio, 0.63 (0.61-0.65) for waist-hip ratio, 0.62 (0.60 -0.64) for waist-circumference, and 0.57 (0.55-0.59) for BMI.
W eight and height are frequent measures of nutritional status. The best anthropometric measure for assessing risks associated with adiposity has not been established. The body mass index (BMI; weight [kg] divided by the square of height [m] ) is the most common measure of overall adiposity in epidemiologic studies. 1 However, the distribution of fat mass may be an even more important predictor of disease. 1, 2 Visceral fat is more metabolically active than subcutaneous fat, 3 and is closely correlated with insulin resistance. [3] [4] [5] [6] Waist circumference (abdominal girth), a measure of both subcutaneous and visceral fat, is easily measured and is often used as a measure of visceral fat in epidemiologic studies. However, waist circumference is also correlated with body-frame size, and the ratio of waist circumference to hip circumference (waist-hip ratio) is often used to take frame size into account. 1 The circumference of the hip, however, is less than perfect as an index of frame size, because it includes pelvic subcutaneous fat mass and muscle mass as well as "horizontal" pelvic bone size. Because height is a measure of body frame size, the ratio of waist circumference to height has been proposed as an alternative to the waist-hip ratio. This latter measure has been found to be slightly superior predicting of metabolic disturbances among Chinese diabetic women, 7 Japanese men, 8 and rural Bangladeshi women. 9 To evaluate and compare these anthropometric measures in a large-scale cohort, we compared waist-height ratio to waist circumference, waist-hip ratio and BMI as predictors of coronary heart disease (CHD, including nonfatal myocardial infarction ͓MI͔ and fatal CHD) in middle-aged and older women in the Nurses' Health Study. We sought to answer 2 primary questions. One, how does the waist-height ratio compare with waist circumference, waist-hip ratio, and body mass index in predicting CHD? Two, what are the relationships between the anthropometric measures and later incidence of CHD?
METHODS

Study Population
The Nurses' Health Study cohort was established in 1976 when 121,700 female registered nurses aged 30 -55 years and living in 11 US states completed and returned a mailed questionnaire about their lifestyle and medical history. The cohort continues to be followed every 2 years by questionnaire to update exposure status and to identify cases of newly diagnosed disease. We restricted our analysis to those 45,563 women who responded to the 1986 questionnaire (when waist circumference was first collected) who were also free of a prior history of heart disease, stroke, or cancer.
Exposure Measurement
Data on height were collected in 1976, weight was collected biennially, and waist circumference and hip circumference measurements were collected in 1986. Women were instructed to use a measuring tape to measure their waist at the level of the umbilicus and their hips at the largest circumference between the waist and the thighs, while standing relaxed; values were recorded to the nearest quarter-inch. In a validation study of the weights reported by the participants, a subsample of 184 women was chosen and weighed 6 -12 months after completing the mailed questionnaire. Reported weights were highly correlated with measured weights (Spearman rank correlation ϭ 0.96), although they averaged 1.5 kg (3.3 lb) lower than the measured values. 10 The measured weights were performed in clothing and at random times of day, explaining much of the increase in measured weight. The validity of measures of waist and hip circumferences were reported previously. 11 In 1987, in a random sample of 140 Nurses' Health Study participants in the greater Boston, Mass., area, an average of 2 measurements by technicians spaced 6 months apart was compared with the waist and hip circumference values reported on the most recent questionnaire. Women reliably reported waist circumference, but underestimated hip circumference by an average of 1.4 cm (0.54 inches). Crude Pearson correlation coefficients for reported and measured circumferences for waist, hip, and waist-hip ratio were 0.89, 0.84, and 0.70, respectively.
12 Waist-height ratio was calculated by dividing the waist circumference reported in 1986 by the height measured in 1976. Body mass index was calculated by dividing the weight reported in 1986 by the square of height reported in 1976 (after converting the reported pounds and inches to kilograms and meters).
Covariate Measurement
Data have been collected on many coronary heart disease risk factors, including cigarette smoking, alcohol use, physical activity, age at menopause, postmenopausal hormone use, diagnosis of hypertension and diabetes mellitus, and parental history of premature myocardial infarction (before age 60).
Outcome Measurement
The end point for this study was incidence of CHD (nonfatal MI or fatal CHD) occurring between the 1986 questionnaire and June 2002. Because a given anthropometric measure is more likely to be predictive of more proximate events, a secondary outcome was CHD occurring within 10 years of start of follow-up. We sought to review medical records for all self-reported MIs. Physicians with no knowledge of the self-reported risk-factor status reviewed the records. The diagnosis of MI was confirmed using World Health Organization criteria, which include symptoms in addition to either diagnostic electrocardiographic changes or elevated cardiac enzyme levels. Event date for coronary heart disease was the earlier date that a diagnosis of MI was made, or a death from CHD.
Deaths were identified from state vital records and the National Death Index, or reported by next of kin and the postal system. Using all sources combined, we estimated that follow-up for the deaths was more than 98% complete. 13 We designated as presumed fatal CHD those deaths for which coronary heart disease was the underlying cause on the death certificate but for which no records were available.
Statistical Analysis
To directly compare how well the anthropometric measures predict CHD risk, we estimated areas under the receiver operating characteristic (ROC) curve. 14, 15 The ROC curve is a plot of the complement of the cumulative distribution of the exposure (waist circumference, waist-height ratio, waist-hip ratio, and BMI) among those who subsequently developed CHD to the complement of the cumulative distribution among those who did not develop CHD; equivalently, this is a plot of the sensitivity versus 1-minus-the specificity. The areas under the ROC curves were estimated nonparametrically.
14 To adjust for covariates, 15 we used residuals from linear regression models with the respective log-transformed anthropometric variable as the response variable and categorical functions of the covariates (indicator functions for quintiles of continuous variables were used) as exposure variables. We also estimated differences between the areas under the ROC curves (AUC) for the waist-height ratio and other anthropometric measures, and their standard errors, by using the algorithm for dependent data developed by DeLong et al. 16 Survival was estimated using the method of KaplanMeier. 17 We calculated person-years from the time of completion of the 1986 questionnaire to the diagnosis of an outcome end point, or censoring, or June 2002, whichever came first. The hazard ratios between linear functions of the anthropometric variables and the observed outcomes were estimated by Cox proportional hazards models. 18 Women were censored if they died of a noncardiac cause or if they developed a stroke. For the purposes of this analysis, censoring was considered noninformative. We used multivariable models to simultaneously control for confounders. To more finely control for confounding by continuous covariates (age, alcohol use), natural cubic splines 19, 20 were used to smooth the relationships with the log-hazard of coronary heart disease. Physical activity was entered into the regression models as indicator functions of the quintiles because natural cubic splines did not determine a good fit for this variable. Ties in survival time were handled by using the method of Efron. 19 To decrease the influence of extreme measurements, we repeated the analyses by restricting the range of the respective anthropometric variables to the 5th through 95th percentiles. Finally, to examine the empiric shape of the relationships to risk of CHD, we repeated the Cox regression models by fitting the anthropometric variables with natural cubic splines, with 4 degrees of freedom, and plotted the results.
Analyses were performed using SAS (version 9; SAS Institute, Cary, NC), S-plus (version 8.0.4; Insightful Corp., Seattle, WA), and Stata (version 9.2; StataCorp., College Station, TX).
Human Subjects
We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during this research. The study was approved by the Committee on Human Research at the Brigham and Women's Hospital.
RESULTS
Among the 45,563 women, during 705,227 personyears of follow-up, these were 790 documented cases of MI and fatal CHD. In 1986, the median (10th, 90th percentiles) waist-height ratio was 0.47 (0.41, 0.57). Median (10th, 90th percentiles) waist-hip ratio, waist circumference, and body mass index were 0.77 (0.70, 0.86), 0.76 meters (0.66, 0.94) ͓30 inches (26, 37)]), and 23.6 kg/m 2 (20.2, 30.2), respectively (Table 1) . Hip circumference, BMI, and waist-hip ratio were all positively correlated with waist-height ratio (data not shown). Quantity of physical activity, alcohol intake, and number of current smokers decreased with increasing waist-height ratio. Table 2 shows the areas under the ROC curves for the anthropometric measures for predicting CHD. As expected, the AUCs were higher for predicting CHD within the first 10 years than over the full 16 years of follow-up. The performances of the various anthropometric measures that included waist circumference were similar to each other in predicting CHD, and superior to BMI (Table 2, Fig. 1 ). The unadjusted AUC for BMI was 0.051 (CI ϭ 0.039 -0.062) less than the unadjusted AUC for waist-height ratio. Adjusted for age, menopausal status, hormone therapy use, parental history of MI, smoking, physical activity, alcohol intake and aspirin use, the AUC for BMI was 0.022 (CI ϭ 0.010 -0.034) less than the adjusted AUC for waist-height ratio. increase in BMI, after adjustment for age, menopausal status, hormone therapy use, parental history of MI, smoking, physical activity, alcohol intake, and aspirin use. Restricting the data to the middle 90% of the respective anthropometric variable resulted in only small changes to the hazard ratios, except for waist-hip ratio for which the hazard ratio per 0.05 increase was 1.25 (1.16 -1.35). Further adjustment for covariates in the biologic pathway relating adiposity to risk of CHD (history of diabetes, hypertension, and hypercholesterolemia) attenuated the hazard ratios for all measures (Table 3 ). Figure  2 and the figures in the online appendix (eFigures 1-3, http://www.links.lww.com/A778) show that linear approximations to the relationship between the anthropometric measures and CHD hazard were less than perfect, in that women with the smallest measurements did not necessarily have the lowest risk of CHD. In a sensitivity analysis that treated strokes and CHD as one outcome, the average adjusted rate ratio corresponding to each 0.05 increase in waist-height ratio was 1.18 (95% CI ϭ 1.15-1.22).
DISCUSSION
We found that the waist-height ratio is comparable to waist-hip ratio and to waist circumference alone, and superior to body mass index, for prediction of coronary heart disease incidence among middle-aged and older women enrolled in the Nurses' Health Study (Table 2) . A number of studies have now established that measures of abdominal adiposity in women are predictive of coronary heart disease independent of body mass index. 11, 21 More recently, some studies have indicated that waist-height ratio may be superior to BMI and waist-hip ratio in some ethnic groups 7,9,22 and in men. 22 Our study, done in middle-aged and older women who were predominantly white, did not find important differences in predicting CHD between waist-height ratio, waist-hip ratio, or waist circumference alone. It is possible that differences in the predictive power of waist-hip ratio between populations may be explained in part by variation in the angle between the sacrum (and pelvis) to the lumbar spine. In this study, excluding the lower and upper 5% of waist-hip ratio measurements resulted in meaningful differences in the hazard ratios. This exclusion had a smaller influence on hazard ratios for other anthropometric measures. This may be related to errors in measurement of the hip circumference, which may be greater than errors in measuring height. An earlier analysis found that participants in the Women's Health Study reliably reported waist circumference, but underestimated hip circumference by an average of 1.4 cm (0.54 inches). 11 The present study used heights measured 10 years earlier than the other measures. On average, height decreases with age in postmenopausal women due to losses in bone mass. 23 This may also be a factor in differences between our results and those from other studies.
As expected, the average risk of CHD increases as each of the anthropometric measures increases. However, the relationship is relatively flat for the lowest levels of the measures as seen in the eFigures (http://links.lww.com/A778). This effect has also been observed in other studies of anthropometric measures. 24, 25 This is consistent with a threshold beyond which increasing adiposity increases risk of CHD. In addition, very low measurements of adiposity often suggest the presence of undernutrition or illness at the time of measurement. We were careful to exclude women who had prior history of heart disease, stroke, or cancer, but this does not rule out the possibility that some women may have had undiagnosed illness at the start of follow-up. An examination of the ROC curves ( Fig. 1) shows that BMI was less discriminating at lower levels (upper regions of the curves) than the waist-based measures.
Major strengths of this study are its prospective nature and its consideration of covariates in the predictive ability of the anthropometric measures. A weakness is that only one measurement was available for the various anthropometric measures, and the resultant measurement error may have led to attenuation of hazard ratio estimates. Given that our definition of CHD is very specific, outcome misclassification is likely to have caused minimal error on our estimates of hazard ratios. 26 By definition, the range for areas under the ROC curve is 0 -1, and values below 0.5 imply that the scale of measure should be reversed, which results in an effective range of 0.5-1. This fact suggests that differences in areas under the ROC curve may be more important, particularly at a population level, than the small values may suggest.
The Cox regression analyses assumed that censoring was uninformative. However, observations were censored in the case of cerebrovascular accidents, which share several similar risk factors with CHD. When we conducted a sensitivity analysis that treated strokes as part of the outcome, the adjusted rate ratio corresponding to each 0.05 increase in waist-height ratio was 1.18 (95% CI ϭ 1.15-1.22) compared with 1.25 (1.19 -1.31) when censoring was treated as uninformative. Although attenuated, the main conclusion remains unchanged.
In efforts to prevent cardiovascular disease and diabetes mellitus, it is important to identify persons at risk. Which waist circumference-based measure offers the best risk stratification remains to be decided. None of these measures was clearly superior to the others among the predominantly postmenopausal women in this study, and the favored measure will likely be determined primarily by ease of measurement. Waist-Height Ratio and CHD Among Women
